Aditxt Inc Stock Investor Sentiment

ADTX Stock  USD 0.32  0.02  5.88%   
Slightly above 62% of Aditxt's investor base is looking to short. The analysis of the overall investor sentiment regarding Aditxt Inc suggests that many traders are alarmed. Aditxt's investing sentiment can be driven by a variety of factors including economic data, Aditxt's earnings reports, geopolitical events, and overall market trends.
  

Aditxt Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Aditxt can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
3 days ago at investing.com         
Aditxt extends merger agreement end date to January 2025
Investing News at Macroaxis
few days ago at news.google.com         
ADTX stock plunges to 52-week low of 0.32 amid market challenges - Investing.com
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
Yahoo News
over two weeks ago at businesswire.com         
Aditxts Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders
businesswire News
over two weeks ago at finance.yahoo.com         
Aditxts Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders
Yahoo News
over two weeks ago at businesswire.com         
Aditxts Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders
businesswire News
over two weeks ago at finance.yahoo.com         
Appili Therapeutics Announces Results of Special Meeting of Shareholders
Yahoo News
over two weeks ago at finance.yahoo.com         
Evofem Secures Investor Support for Proposed Merger through Voting Agreements
Yahoo News
over two weeks ago at finance.yahoo.com         
Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for ...
Yahoo News
over two weeks ago at businesswire.com         
Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for ...
businesswire News
over two weeks ago at businesswire.com         
Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for ...
businesswire News
over two weeks ago at news.google.com         
ADTX - Aditxt, Inc. Latest Stock News Market Updates - StockTitan
Google News at Macroaxis
over two weeks ago at businesswire.com         
Aditxts Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requireme...
businesswire News
over two weeks ago at businesswire.com         
Aditxts Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requireme...
businesswire News
over three weeks ago at businesswire.com         
Aditxt To Host Virtual Stakeholder Update and QA Session on Friday, November 1, 2024, at 1130 AM Eas...
businesswire News
Far too much social signal, news, headlines, and media speculation about Aditxt that are available to investors today. That information is available publicly through Aditxt media outlets and privately through word of mouth or via Aditxt internal channels. However, regardless of the origin, that massive amount of Aditxt data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aditxt news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aditxt relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aditxt's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aditxt alpha.

Aditxt Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Insider Trading
09/13/2024
2
Aditxts Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025
09/20/2024
3
Aditxts Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appilis Sh...
10/10/2024
4
Acquisition by Shabahang Shahrokh of 138 shares of Aditxt at 2.38 subject to Rule 16b-3
10/11/2024
5
Disposition of 25534 shares by Hrt Financial Lp of Aditxt at 1.17 subject to Rule 16b-3
10/16/2024
6
Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD Media Personality Dr. Drew Pinsky, on Octo...
10/21/2024
7
Sylvia Hermina Joins Aditxts Board of Directors, Elevating Leadership with Broader Perspectives
10/29/2024
8
Aditxts Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submissio...
10/31/2024
9
Evofem Secures Investor Support for Proposed Merger through Voting Agreements
11/06/2024
10
Aditxts Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders
11/07/2024
11
Aditxt extends merger agreement end date to January 2025
11/19/2024

Additional Tools for Aditxt Stock Analysis

When running Aditxt's price analysis, check to measure Aditxt's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aditxt is operating at the current time. Most of Aditxt's value examination focuses on studying past and present price action to predict the probability of Aditxt's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aditxt's price. Additionally, you may evaluate how the addition of Aditxt to your portfolios can decrease your overall portfolio volatility.